ORCID Profile
0000-0002-1966-2886
Current Organisations
University of South Australia
,
AllWater
Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the Feedback Form.
Publisher: Springer Science and Business Media LLC
Date: 09-06-2018
DOI: 10.1007/S11356-018-2464-6
Abstract: The occurrence and fate of five drugs of abuse in raw influent and treated effluent wastewater were investigated over a period of 1 year in the Adelaide region of South Australia. Four wastewater treatment plants were chosen for this study and monitored for five drugs which included cocaine in the form of its metabolite benzoylecgonine (BE), meth hetamine, 3,4-methylenedioxymeth hetamine (MDMA) and two opioids (codeine and morphine) during the period April 2016 to February 2017. Alongside concentrations in raw sewage, the levels of drugs in the treated effluent were assessed and removal efficiencies were calculated. Drug concentrations were measured by mixed-mode solid phase extraction and liquid chromatography coupled to a quadrupole mass spectrometer. Drug concentrations detected in the raw wastewater ranged from 7 to 6510 ng/L and meth hetamine > morphine > MDMA > BE. Results showed that all the targeted drugs were on average incompletely removed by wastewater treatment, with removal performance highest for morphine (94%) and lowest for MDMA (58%). A screening-level environmental risk assessment was subsequently performed for the drugs based on effluent wastewater concentrations. Based on calculated risk quotients, overall environmental risk for these compounds appears low, with codeine and meth hetamine likely to pose the greatest potential risk to receiving environments. Given the recognised limitations of current ecotoxicological models and risk assessment methods for these and other pharmaceutical drugs, the potential for environmental impacts associated with the continuous discharge of these compounds in wastewater effluents should not be overlooked.
Publisher: Elsevier BV
Date: 11-2016
Publisher: MDPI AG
Date: 22-02-2019
DOI: 10.3390/W11020377
Abstract: Emerging contaminants of concern have become a serious issue for the scientific community and society more broadly in recent years due to their increasingly widespread environmental distribution and largely unknown environmental and human health impacts. This study aimed to explore the use of fluorescence excitation-emission (F-EEM) spectroscopy as an alternative analytical method to evaluate the presence of key drugs of addiction (benzoylecgonine, meth hetamine, MDMA, codeine and morphine) in wastewater treatment plants. The chemicals of interest from wastewater were extracted by mixed-mode solid phase extraction and quantified using liquid chromatography tandem mass spectrometry. The same wastewater s les were also analysed by a fluorescence spectrophotometer for fluorescence spectra at wavelengths 280–600 nm (emission) and 200–600 nm (excitation). The study also investigated the relevance of different methods for interpreting F-EEM matrices data including parallel factor analysis (PARAFAC) modelling and fluorescence regional integration technique. PARAFAC identified four components, and among them, component C2, identified at the λex/λem = 275/340 nm wavelength associated with proteinaceous compounds most likely related to tryptophan amino acid, showed significant correlation with codeine removal. MDMA and morphine were not correlated to any of the fluorescence regions. The fluorescence regions related to aromatic protein-like fluorescence were correlated significantly with drug concentration and so may offer a suitable alternative approach for monitoring drugs including benzoylecgonine, meth hetamine and codeine.
Publisher: Elsevier BV
Date: 11-2017
DOI: 10.1016/J.WATRES.2017.07.068
Abstract: This review critically evaluates the types and concentrations of key illicit drugs (cocaine, hetamines, cannabinoids, opioids and their metabolites) found in wastewater, surface water and drinking water sources worldwide and what is known on the effectiveness of wastewater treatment in removing such compounds. It is also important to amass information on the trends in specific drug use as well as the sources of such compounds that enter the environment and we review current international knowledge on this. There are regional differences in the types and quantities of illicit drug consumption and this is reflected in the quantities detected in water. Generally, the levels of illicit drugs in wastewater effluents are lower than in raw influent, indicating that the majority of compounds can be at least partially removed by conventional treatment processes such as activated sludge or trickling filters. However, the literature also indicates that it is too simplistic to assume non-detection equates to drug removal and/or mitigation of associated risks, as there is evidence that some compounds may avoid detection via inadequate s ling and/or analysis protocols, or through conversion to transformation products. Partitioning of drugs from the water to the solids fraction (sludge/biosolids) may also simply shift the potential risk burden to a different environmental compartment and the review found no information on drug stability and persistence in biosolids. Generally speaking, activated sludge-type processes appear to offer better removal efficacy across a range of substances, but the lack of detail in many studies makes it difficult to comment on the most effective process configurations and operations. There is also a paucity of information on the removal effectiveness of alternative treatment processes. Research is also required on natural removal processes in both water and sediments that may over time facilitate further removal of these compounds in receiving environments.
No related grants have been discovered for Meena Yadav.